SciELO - Scientific Electronic Library Online

vol.21 issue4Effects of an educational intervention in the attitude of donating organs in schoolchildren in the commune of TalcahuanoAssessing the impact of a training program in motivational interviewing to nephrology nursing author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Enfermería Nefrológica

On-line version ISSN 2255-3517Print version ISSN 2254-2884


BONACHE TUR, Débora et al. Results of immunoadsorption in the ABOi kidney transplantation and humoral rejection in a hospital hemodialysis unit. Enferm Nefrol [online]. 2018, vol.21, n.4, pp.386-392. ISSN 2255-3517.


The non-selective immunoadsorption treatment was introduced in our hospital hemodialysis unit with the aim of allowing desensitization prior to a kidney transplant with blood group incompatibility and the treatment of antibody-mediated rejection.


To analyze the results of the non-selective immunoadsorption technique in a hospital hemodialysis unit.

Material and methods:

Retrospective descriptive study of the first 18 patients treated in our center with non-selective immunoadsorption (years 2012-2017) in the indications for ABOi transplant conditioning and treatment of humoral rejection.


During a period of 5 years, 128 non-selective immunoadsorption sessions were analyzed. 38.9% (n= 7) of cases for desensitization prior to renal transplantation with incompatibility of blood group and 61.1% (n=11) remaining for the treatment of antibody-mediated rejection.

In the first case, an average of 8±0.6 sessions of immunoadsorption prior to kidney transplantation were performed and 57.1% were complemented by 2 subsequent sessions. The concomitant treatment was protocolled with rituximab and immunoglobulins, 57.1% requiring plasma exchanges. In the second case, an average of 5.9±2 immunoadsorption sessions were carried out. The concomitant treatment was the same and 27.3% performed plasma exchanges.


Kidney transplantation from ABOi living donor after desensitization was possible in 100% of patients. 72.7% of patients treated for antibody-mediated rejection currently maintain graft functionality.

Keywords : kidney transplantation; blood group incompatibility; immunosorbent technique; desensitization; rituximab.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )